Zheng Quan Zhi Xing·2025-08-04 16:12Group I - The report details the changes in the registered capital of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. as of July 31, 2025, indicating no increase or decrease in the registered capital for the month [1]. - The total registered capital at the end of the month is RMB 2,670,429,325, with no changes reported from the previous month [1]. - The number of issued shares (excluding treasury shares) remains unchanged at 540,971,500 for the security code 02196 and 2,098,582,573 for the security code 600196 [1]. Group II - The report confirms that all securities issuance or treasury share transactions have been authorized by the board of directors and comply with applicable listing rules and regulations [2]. - It states that all necessary conditions for listing have been fulfilled, and all required documents have been filed with the relevant authorities [2]. - The report also confirms that all ownership documents related to the issuance, sale, or transfer of shares have been prepared and sent as required [2].